Frazier Life Sciences Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,430	Closed	-$10.2M	–	54
2023 Q2	$10.2M	Buy	+100,430	New	+$10.2M	0.61%	31